At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 123 enrolled
Drug / intervention
Furosemide +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Randomized Study Evaluating the Efficacy and Safety of Early Diuresis Following Colorectal Surgery
In Brief
A Phase 4 clinical trial evaluating Furosemide, Celecoxib, and 1 other intervention for Colorectal Disorders. Completed, enrolled 123 participants across 1 site.
Detailed Summary
The purpose of this study is to find out if giving a medicine called furosemide, which is a diuretic or water pill, after colon surgery will safely shorten the patient's length of hospital stay.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Disorders
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 2015
Enrollment StartFeb 2015
Primary CompletionApr 2016
TodayJul 2026
First PostedJan 30, 2015
Enrollment StartFeb 1, 2015
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 11.4 years ago
Interventions
Furosemidedrug
Celecoxibdrug
Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain or inflammation.
Gabapentindrug
Gabapentin is a oral drug used to treat seizures, postherpetic neuralgia, and restless legs syndrome.